Head and Neck Cancer: Link with Human
Papillomavirus (HPV)
Transcript:
Guest: Dr.
Boyd Gillespie - Otolaryngology
Host: Dr.
Linda Austin – Psychiatry
Dr. Linda Austin:
I’m Dr. Linda Austin. I’m
interviewing Dr. Boyd Gillespie who is Associate Professor of Otolaryngology,
or Ear, Nose & Throat, here at the Medical University of South
Carolina. Dr. Gillespie, there’s been a
lot of interest recently in the news about the relationship between HPV, or
human papillomavirus, and cancers of the head and neck. What is that relationship?
Dr. Boyd Gillespie:
Just stepping back a minute, cancers of the head and neck are cancers
that involve several different sites, including cancer of the lips, jawbone,
tongue, the palate area, the back of the throat, or the larynx, and the
pharynx. The back of the throat includes
the tonsils and basic tongue region.
There are approximately 40,000-50,000 cases of head and neck cancer per
year in the United States. Traditionally, these cancers have been
related to tobacco use and alcohol use.
However, over the past 10 years, we’ve noted a rise
in patients with head and neck cancers who have very minimal tobacco exposure,
particularly cancers of the tonsil and tongue base region. This led investigators, about 10-15 years ago,
to study other possible causes of head and neck cancer. We knew from earlier research that cancers
that appear similar to these head and neck cancers occurred in the uterine
cervix in women, cervical cancer in women.
That’s why women get a yearly pap smear.
Under the microscope, these tumors appeared very similar to some of
these cancers that we were seeing in the tonsil and tongue region.
We knew from earlier research that these cervical
cancers in women were caused by human papillomavirus. Human papillomaviruses are a broad class of
viruses. They’re DNA viruses. There are over 100 different subtypes of
these. Commonly, they’re the type of
viruses that cause warts on the skin.
The can also cause genital warts and other growths in the body. Out of those 100 different subtypes, there
are only five to seven that have the potential to be malignant. So, most of them cause benign growths, but
there are certain subtypes of human papillomavirus that can cause malignant
growths.
From this earlier research in the obstetrics and
gynecology field, we knew that these tumors were related to human
papillomavirus. Because of the similar
appearance of these tumors in the head and neck region, we also began using
molecular methods to test these tumors and we found that, indeed, these tumors
were also positive for human papillomavirus.
So, the current feeling is that up to 25 percent of head and neck
cancers are likely related to human papillomavirus.
If you look at specific sites within the head and
neck, such as the tonsil or tongue base, up to 60 percent of these cancers are
HPV positive. And, unfortunately, what
we’ve seen is, as the number of smokers in our population has gone down, we
have, indeed, seen a decrease, overall, in certain head and neck cancers,
however cancers of the tonsil and tongue are starting to go up, and these are
the ones related to the HPV virus. So,
it’s becoming a major concern among head and neck surgeons who are interested
in getting the word out about risk factors for this type of head and neck
cancer.
Dr. Linda Austin:
Now, most people, I think, know by this time that there’s been a very
strong push to get young girls and women vaccinated against the HPV virus
because, obviously, the cervix is something girls have and boys don’t. These HPV positive cancers, though, of the
tongue and tonsils, are they equally common in boys?
Dr. Boyd Gillespie:
Right now, we see slightly more of these HPV head and neck cancers in
men than women, but we do them in both.
Some of the potential epidemiological things that have been looked at
are the number of lifetime sexual partners, early onset of sexual contact and
oral sexual involvement. The people who
fit that profile are a little bit more at risk.
However, that’s not true for everyone.
We don’t know if it’s directly due to a sexual mode of spread or if it
can be spread through other ways, such as saliva or skin contact.
Dr. Linda Austin:
I know that among adolescents, oral sex is becoming almost a method of
birth control. It certainly is effective
for birth control, but one wonders if it may not lead to this increased rate
that you’re seeing now.
Dr. Boyd Gillespie:
That’s one reason why head and neck surgeons are interested in informing
the public that a lot of people are under the impression that oral sex is a
safer method of sex. Certainly, from the
standpoint of pregnancy, that’s true.
But from the standpoint of sexually transmitted diseases, it’s not
true. There are sexually transmitted
diseases, a variety of which, chlamydia, gonorrhea, HPV, can be spread through
oral sex. Unfortunately, this type of
sexually transmitted disease can also lead beyond the infection itself to
precancerous and cancerous changes.
Therefore, I think it’s just good for people to be to be informed of
their risk factors and to take that into account with their behavior.
Dr. Linda Austin:
Is there a recommendation that boys should be vaccinated then?
Dr. Boyd Gillespie:
A lot of people are coming to that conclusion. Right now, there is no policy for that and,
unfortunately, third party payers are not covering that. But, it makes sense. I mean, the way young women get this virus is
through contact with young men, so young men are carriers of the virus. We know that only women can get cervical
cancer. They get it from their contact
with men who are carriers of the virus.
So, a lot of people are of the opinion that boys should be vaccinated. It’s my feeling that within a few years, that
will be public policy.
Dr. Linda Austin:
I’ve heard it said, even aside from the issue of the tongue and
tonsillar cancers, that if we don’t vaccinate the boys, we won’t be able to get
a handle on this virus because they are the reservoir for it; they carry
it.
Dr. Boyd Gillespie:
That’s true. It’s been estimated
that at any given time, up to 10 percent of the population is carrying HPV of
some type. And up to 30 or 40 percent of
the population has exposure during their lifetime. That’s a tremendous number of people. Luckily, very few of those people will go on
to develop cancers of the cervix or the head and neck region. So, there are other factors beyond just the
viral infections themselves that likely lead to cancers. There may be relationships with a person’s
immune system or their underlying genetics that make them more susceptible to a
cancer from the HPV virus.
Dr. Linda Austin:
How deadly of a cancer is this?
Dr. Boyd Gillespie:
Head and neck cancers are very deadly.
Early signs of head and neck cancer include sore throat, swallowing difficulty,
a white or red patch on the inside of the throat, bleeding around the gums or
throat, hoarseness. Late signs include
developing a mass or lump in the neck region.
That’s an indication that the cancer has spread from the throat to some
of the lymph nodes. Unfortunately, up to
half of our patients present, already, at that level. So, half of our patients coming already have
a mass in their neck, and that reduces their likelihood of survival by 50
percent.
My recommendation is, anyone who has a sore or an
irritation in the throat that doesn’t clear up within two weeks should have
that evaluated to rule out the possibility of a cancer. One reason why we want to make the public
aware of the relationship between HPV virus and head and neck cancer is that a
lot of people who develop these symptoms who don’t smoke are of the opinion
that, how could I have a head and neck cancer, I don’t even smoke. Well, again, up to 25 percent of our head and
neck cancer patient population, really, had minimal to no smoking history. So, people can get head and neck cancer who
have never even touched a cigarette.
It’s important for people to be aware of the signs and symptoms and if
they’re experiencing those to come in for an evaluation.
Dr. Linda Austin:
Dr. Gillespie, thank you so much for talking with us.
Dr. Boyd Gillespie:
Thank you.
If you have any questions about the services
or programs offered at the Medical University of South
Carolina or if you would like to schedule an
appointment with one of our physicians, please call MUSC Health
Connection: (843) 792-1414.